Page last updated: 2024-12-06

1'-hydroxysafrole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

1'-Hydroxysafrole (1'-HS) is a **metabolite** of safrole, a naturally occurring compound found in various plants, including sassafras trees and nutmeg.

**Why is it important for research?**

1'-HS is **not** a direct research subject itself, but rather its **biological activity** and **relationship to safrole** make it crucial for various research fields:

* **Pharmacology and Toxicology:**
* 1'-HS is considered a **potential carcinogen** and its metabolism is linked to liver damage. This makes it important for studying the toxic effects of safrole and other related compounds.
* Research on 1'-HS helps understand the **mechanisms of carcinogenesis** and develop strategies for preventing or treating liver cancer.

* **Drug Development:**
* The biological activity of 1'-HS is investigated for its potential applications in **drug development**.
* Researchers explore its potential therapeutic effects on various diseases, including cancer.

* **Botanical Research:**
* Studying 1'-HS helps understand the **biochemical pathways** involved in the metabolism of safrole and other natural compounds.
* This knowledge is crucial for identifying and evaluating the potential **health benefits and risks** of plants containing these compounds.

**Important Note:**

1'-HS is a **highly reactive and potentially toxic compound**. It is **not recommended** to consume or handle it without proper safety precautions and professional guidance.

**In summary:**

1'-HS plays a significant role in various research fields due to its connection to safrole and its biological activity. Research on 1'-HS contributes to our understanding of toxicity, carcinogenesis, drug development, and the properties of natural compounds. However, it's crucial to remember the potential risks associated with this compound.

Cross-References

ID SourceID
PubMed CID21268
SCHEMBL ID6869336
MeSH IDM0059349

Synonyms (32)

Synonym
5208-87-7
1'-hydroxysafrole
1-(1,3-benzodioxol-5-yl)prop-2-en-1-ol
1'-hyroxysafrole
ccris 341
1,3-benzodioxole-5-(2-propen-1-ol)
hsdb 3492
1,3-benzodioxole-5-methanol, alpha-ethenyl-
1,2-methylenedioxy-4-(1-hydroxyallyl)benzene
piperonyl alcohol, alpha-vinyl-
brn 0167676
alpha-ethenyl-1,3-benzodioxole-5-methanol
AKOS006275901
unii-c9b19855e2
c9b19855e2 ,
4-19-00-00802 (beilstein handbook reference)
.alpha.-vinyl-1,3-benzodioxole-5-methanol
1,3-benzodioxole-5-methanol, .alpha.-ethenyl-
piperonyl alcohol, .alpha.-vinyl-
.alpha.-ethenyl-1,3-benzodioxole-5-methanol
2-(3,4-methylenedioxyphenyl)allyl alcohol
1'-hydroxyisosafrole
1'-hydroxysafrole [hsdb]
SCHEMBL6869336
DTXSID0020731
1-(2h-1,3-benzodioxol-5-yl)prop-2-en-1-ol
1-(benzo[d][1,3]dioxol-5-yl)prop-2-en-1-ol
CS-0267130
Q27275352
EN300-1995939
1-(1,3-dioxaindan-5-yl)prop-2-en-1-ol
STARBLD0032503

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (73.33)18.7374
1990's0 (0.00)18.2507
2000's2 (13.33)29.6817
2010's1 (6.67)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.72 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]